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significantly higher in the wound blush-positive group than in the wound blush-
negative group, and remained so for at least 3 years after the EVT (96.4% vs. 56.8%,
P<0.001).
Conclusion: Wound blush as an angiographic endpoint in EVT may be a novel
predictor of limb salvage in patients with CLI.
TCT-594
Clinical Outcomes Using the Viabahn Stent Graft in Complex Femoropopliteal
Lesions
Peter Mohr, Curtiss Stinis
Scripps Clinic, La Jolla, CA
Background: The optimal endovascular treatment for complex femoropopliteal (FP)
disease is unknown. Percutaneous transluminal angioplasty (PTA) carries a high rate
of restenosis while nitinol stent implantation can result in fractures. The Viabahn stent
graft (Gore Medical; Flagstaff, AZ) was developed to reduce restenosis and increase
overall flexibility. The purpose of this study was to evaluate the efficacy of the Viabahn
stent graft in complex FP disease.
Methods: We evaluated 57 limbs in 48 patients receiving Viabahn stent grafts. Patient
demographics, comorbidites, and procedural details were collected. Outcomes included
primary patency, assisted primary patency, secondary patency, and pre- and
postprocedural ankle brachial index and Rutherford classification.
Results: The study group consisted primarily of TASC II C (n=27;47%) and D
(n=24;42%) lesions (mean age 74.5; male sex=68%). Indications for revascularization
were lifestyle limiting claudication (70.2%), critical limb ischemia (28.1%), and
popliteal aneurysm exclusion (8.8%). Twenty-six patients (46%) had undergone
previous PTA, and 8 patients (14%) had undergone previous peripheral bypass. The
average graft length was 25.4 cm, with an average of 2.1 grafts implanted. There were
no periprocedural complications. Follow-up was available for 53 limbs (93%) with a
mean follow-up of 8.5 months (range 1-22). Average ABI improved from 0.59 to 0.96.
Eight limbs (15.1%) experienced restenosis and 5 limbs (9.4%) had an occlusion. The
primary patency rate for the mean follow-up time was 75.5%. Assisted primary patency
was 90.6% (all restenotic limbs successfully revascularized) and secondary patency
was 96.2% (3 of 5 occlusions with restored patency). At follow-up, 42 patients (80.8%)
were symptom free, 8 patients (15.4%) had Rutherford Class 2-3 symptoms, and 1
patient (1.9%) had critical limb ischemia.
Conclusion: Viabahn stent grafting is a safe and effective option for patients with
complex FP lesions. Patency rates are favorable despite the complexity of disease.
Restenosis and occlusion, while uncommon, can occur which mandates close follow-
up.
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One year clinical outcomes of MISAGO2 the large multicentre study with
Misago the new self-expanding nitinol peripheral stent - final results
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Background: The main purpose of this study was to assess on the large patient
population the performance and clinical outcome of Misago SX nitinol stent in the
treatment of superficial femoral (SF) or popliteal arteries
Methods: MISAGO 2 registry enrolled 744 patients undergoing percutaneous
intervention of stenotic or occluded lesions in SF or popliteal arteries in 76 centres
across Europe. In total 754 lesions were treated with 916 stents. All clinical events are
independently adjudicated. The primary endpoint was absence of clinically driven
target lesion revascularization at 6 and 12 months.
Results: Patients (67% male) were 69±10 years old, 68% had hypertension, 60% were
smokers and 35% diabetes. Average lesion length was 64±38 mm, 38% lesions were
totally occluded and 64% massively or moderately calcified. Technical and procedural
success rates were 99%. 12-Month follow-up done on more than 90% of the subjects
treated at baseline (655) showed freedom from target lesion revascularization of 89.6%
and primary patency rate of 87.6%. Total number of subjects with any adverse event
(any death, amputation, revascularization, vascular, bleeding and cerebrovascular
event) was 14.8%. Ankle brachial index increased for more than 0.1 in 76% of the
subjects, and Rutherford index improved in 87% of the subjects. There was no
clinically relevant (grade 3&4 out of 4)stent fracture reported in the study. Overall
fracture rate was 3.1.
Conclusion: Results of the large multicentre MISAGO 2 registry that evaluated
Misago RX system in SFA and popliteal arteries showed excellent TLR and primary
patency rate at one year. Low fracture rate observed was not related with any of TLR
occurred.
TCT-596
Factors Related to the Failure of Limb Salvage Following Endovascular
Therapy in Patients with Critical Limb Ischemia
Shin Okamoto, Osamu Iida, Masaaki Uematsu
Kansai Rosai Hospital, Amagasaki city, Japan
Background: Although endovascular therapy (EVT) has been shown efficacious in
patients with critical limb ischemia (CLI), EVT is not always successful in limb
salvage. We sought to investigate the factors related to the failure of limb salvage
following EVT.
Methods: Consecutive 358 legs from 307 CLI patients (Rutherford 4 to 6) who
underwent EVT were enrolled between April, 2003 and April, 2009. Primary endpoint
comprised amputation or bypass surgery. Patients were followed for 20 +/- 16 months.
Logistic regression analysis was performed to explore the independent determinants
of the prognosis of the legs.
Results: Initial success rate was 86%. Bypass surgery or amputation was done in 78
limbs. Age, ankle brachial index, hypertension, Rutherford class and distal blood flow
below the ankle were chosen as independent variables by single regression analysis.
Among these, distal blood flow was chosen as the strongest independent predictor
associated with the prognosis of the legs by multivariate analysis (Table).
Conclusion: Poor flow below the ankle was the strongest factor related to the failure
of limb salvage following EVT.
TCT-597
Utilization of Imaging Modalities Prior to Amputation Among Patients With
Peripheral Arterial Disease or Diabetes — A Nationwide Study
Sumeet Subherwal1, Emil L Fosbol1, 3, Lars Kober2, William S Jones1, Gunnar H
Gislason3, Christian Torp-Pederersen3, Manesh R Patel1
1Duke Clinical Research Institute, Duke University, Durham, NC; 2The Heart
Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; 33.
Department of Cardiology, Copenhagen University Hospital Gentofte,, Copenhagen,
Denmark
Background: Non-traumatic lower extremity amputation is associated with significant
morbidity and mortality. With the emergence of newer improved therapies for
revascularization, the use of imaging to identify treatable disease prior to amputation
is not known.
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Methods: Using nationwide administrative registries in Denmark from 2000-2009 we
sought to describe the use of various lower extremity imaging modalities (CTA, MRA,
angiography, and Doppler ultrasound) 1-year prior to lower extremity amputation.
Analysis was limited to patients > 40 years with first amputation for a primary
diagnosis of lower extremity peripheral arterial disease (PAD) or diabetes (DM).
Results: Among the 7,748 patients (58.5% male, mean age 74.1 + 11.6 years) that
underwent an amputation, 5,607 had PAD and 2,141 had DM as the primary cause for
amputation. Use of imaging modalities 1-year prior to amputation was modest; nearly
2/3rd of the amputations were performed without imaging 1 year prior to surgery
(Table). One-year mortality was 33% among patients who were imaged vs 40% among
those who were not. Overall, one-year mortality was 38% (29% for DM and 42% for
PAD).
Rates of Imaging 1-Year Prior to Amputation
Conclusion: The most common imaging modality used 1-year prior to amputation for
PAD or DM was angiography. However, most amputations occur without any imaging
1-year prior to surgery; this represents an opportunity to identify anatomical severity
and modify treatment, especially given the high mortality after amputation.
TCT-598
Paradigm Shift in Ruptured AAA (RAAA) Management; Twelve years
experience in a tertiary referral centre of Endovascular repair of
RAAA(REVAR) vs open repair (OR)
Sherif Sultan1, 2, Wael Tawfick1, Niamh Hynes2, 1
1Vascular & Endovascular Surgery, Western Vascular Institute, Galway, Ireland;
2Galway Clinic, Galway, Ireland
Background: Out of 683 AAA operated upon, 120 patients presented with RAAA over
12 years, 42 had REVAR and 78 had OR.
Methods: During 20th century 95% of all AAA were done surgically. However during
21st century 80% of AAA is done endovascularly. Mean Annual number of OR dropped
from 19+/-3.6 to 18+/-7.8,P<0.845, however Mean Annual number of EVARs had
rocketed to 26+/-6.1 P<0.006 . Overall number of AAA repairs has increased by 65%
over twelve years period and number of EVAR has increased by 80% but the absolute
number of RAAA had declined.
Results: Total Emergency mortality rate decreased from 64% to 28.2%. Low Mortality
Rate of 16%for REVAR Vs 32%in OR is due to introduction of an REVAR Programme
which constitutes screening for prevention with early intervention and REVAR for
rupture which has an absolute perioperative mortality reduction of 49% over OR. Table
5 years Survival of Patients with RAAA were 75% REVAR vs. 60% OR (p=0.0205)
Conclusion: Para-Millennium and Contemporary Trends in AAA Management had
shown Increased in Elective EVAR which increased the mortality advantage in favour
of REVAR and it should be Gold standard for RAAA.
TCT-599
Results of the U.S. IDE Study of the Wildcat Catheter (CONNECT)
John P Pigott1, Tom Davis2, M. Laiq Raja3, John B Simpson4
1Jobst Vascular Institute, Toledo, OH; 2St John Hospital and Medical Center,
Detroit, MI; 3El Paso Cardiology Associates, El Paso, TX; 4Sequoia Hospital,
Redwood City, CA
Background: Percutaneous techniques for crossing femoropopliteal chronic total
occlusions (CTOs) offer an alternative to bypass surgery in high-risk patients. The
Wildcat CTO catheter uses a rotating distal tip and deployable wedges to improve
operator device control and create more reliable true lumen passage. We report the
final results of 88 patients enrolled in the Wildcat catheter trial. The FDA recently
granted conditional approval for 50 additional patients which will be incorporated into
the presentation.
Methods: This is a prospective, multicenter, nonrandomized trial. Enrolled patients
with a CTO of the femoropopliteal arteries were unable to be successfully crossed with
initial guidewire techniques. The primary measured efficacy endpoint is guidewire
placement into the true distal lumen after Wildcat passage confirmed by angiography.
Secondary safety/efficacy endpoints were assessed within 30 days. Procedural site
reporting was independently ratified by board-certified angiographic reviewers.
Results: 88 patients were enrolled with an average CTO length of 174 ± 96mm, 89%
of which were de novo lesions. 55% of lesions demonstrated at least moderate
calcification and >85% of vessels were superficial femoral arteries. The device was
used in 84/88 patients. Successful CTO crossing was reported in 89.3% of cases with
95.2% freedom from major adverse events or clinically relevant complications (Table).
Primary Safety
Conclusion: The Wildcat CTO catheter demonstrated an 89.3% crossing rate with little
associated morbidity. Results surpassed study design endpoints.
TCT-600
The OCELOT Catheter for Long SFA Occlusions–The Six Months Follow Up
R. Stefan Kiesz1, Przemyslaw Nowakowski2, Stanislaw Trznadel2, Aleksander
Zurakowski2, Pawel Cwik2, Jacek Czarny2, Barbara Wiernek2, Magda Konkolewska1,
Pawel E Buszman2
1San Antonio Endovascular & Heart Institute, San Antonio, TX; 2American Heart of
Poland - Dep. of Vascular Surgery, Chrzanow, Poland
Background: The OCELOT catheter is an atherectomy device with integrated Optical
Coherence Tomography (OCT). By using OCELOT, the operator (while passing the
catheter through-out the occlusion), is oriented in which layer of the vessel he is at the
given moment. It allows to keep the device intraluminal without the subintimal
penetration.
Methods: In August 2010, 10 patients (9 male) with Chronic Total Occlusion (CTO)
of the SFA (length of occlusion between 50-100mm) and claudication distance <200m
underwent 10 endovascular procedures with the use of the OCELOT catheter.
Results: The procedural success was 90%. In one case we were unable to cross the
occlusion because of the severe calcification of the artery. Balloon Angioplasty alone
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